The Watchman saga--closure at last?

N Engl J Med. 2015 Mar 12;372(11):994-5. doi: 10.1056/NEJMp1415738.

Authors

Daniel B Kramer¹, Aaron S Kesselheim

Affiliation

¹ From Harvard Medical School (D.B.K., A.S.K.), the Cardiovascular Institute, Beth Israel Deaconess Medical Center (D.B.K.), the Hebrew SeniorLife Institute for Aging Research (D.B.K.), and the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital (A.S.K.) - all in Boston.

No abstract available

MeSH terms

Atrial Appendage
Atrial Fibrillation / therapy*
Device Approval* / legislation & jurisprudence
European Union
Government Regulation*
Humans
Product Surveillance, Postmarketing*
Prostheses and Implants*
Thromboembolism / prevention & control*
United States
United States Food and Drug Administration

Grants and funding

K23 AG045963/AG/NIA NIH HHS/United States